Neurocrine Biosciences


Neurocrine Biosciences
$85.11 -$4.72 -5.3%
BATS BZX Real Time Price as of March 22, 2019, 4:00 p.m. View Interactive NBIX Charts

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.

News & Analysis: Neurocrine Biosciences

The Fool has written over 100 articles on Neurocrine Biosciences.
Market Moves

3 Top Biotech Stocks to Buy in May

Looking for a few timely buys in the biotech space? Give these gems a closer look.

Interactive Chart